A Case-Controlled Study of the Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunts After Liver Transplantation.'' 1 We published the outcomes for 26 patients who underwent transjugular intrahepatic portosystemic shunt (TIPS) placement for intractable ascites after liver transplanta
Transjugular intrahepatic portosystemic shunt to keep vein open
โ Scribed by Patrick P. McHugh; Gabriel J. Bietz; Hoonbae Jeon; Thomas D. Johnston; Roberto Gedaly; Dinesh Ranjan
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 186 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21645
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
jects. However, it is self-limited and rarely requires SEE EDITORIAL ON PAGE 177. intervention. Potential mechanisms of such hemolysis are discussed. TIPS is also not recommended as a means of improving platelet counts in patients with Transjugular intrahepatic portosystemic shunts (TIPS) severe hyp
## BACKGROUND. Transjugular intrahepatic portosystemic shunt (TIPS) placement has emerged as an effective and minimally invasive method of treating portal hypertension and its associated complications. To the authors' knowledge there is limited documentation of its use for percutaneous shunting in
Background: Transjugular intrahepatic portosystemic shunts (TIPS) have been used to control symptomatic portal hypertension in patients awaiting liver transplant. Although their role in pretransplantation patients is well established, their role in posttransplantation patients is unclear. Study Desi
venous pressure and the severity of PSE after TIPS are inversely related. 12 In 1992, Sanyal et al reported a post-TIPS patient with Naked we came into the world, and naked we shall depart hemolytic anemia and progressive hepatic encephalopathy from it. (HE), which they attributed to the stent, 13